29/08 2023 Regulatory Interim Report Q2 – April – June, 2023 Redsense Medical AB (publ) APRIL – JUNE 2023 · Net sales amounted to kSEK 4,831 (1,927), an increase of 151%. · Operating loss, EBIT amounted to kSEK 3,045 (2,428).… [read more]
15/08 2023 Regulatory Redsense secures strong autumn with MSEK 11.2 order Redsense Medical has received a new order valued at MSEK 11.2 from one of its U.S. distributors. “This order will be delivered during the autumn… [read more]
07/07 2023 Non-regulatory Redsense Medical’s alarm system featured in KFF Health News Redsense Medical was discussed in a KFF Health News report that highlighted the potentially fatal danger of Venous Needle Dislodgement (VND) and emphasized the need… [read more]
